April 9, 2009

Psoriasis Drug Raptiva Voluntarily Recalled by Drug Maker

Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), said it has begun a "voluntarily" recall of the drug from the market due to serious patient safety risks following an FDA report indicating that three patients using Raptiva died of progressive multifocal leukoencephalopathy (PML), a rare, serious, progressive neurological disease caused by a virus that affects the central nervous system. The company said that doctors should immediately stop prescribing the drug. In its February report, the FDA recommended that doctors carefully monitor current and former users of Raptiva for signs of neurological diseases, but stopped short of taking any action that would recall the drug at that time. Genetech estimates that about 2,000 patients in the U.S. are currently taking Raptiva for chronic psoriasis.

Click here to learn more about Raptiva recall

Click here to view FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market

Best Law Firms Badge 2010 Best Law Firms Badge 2011-2012 Best Law Firms Badge 2013 Best Law Firms Badge 2014 Best Law Firms Badge 2015 Listed in Best Lawyers 2015 2015 Legal Leaders - Top Rated Lawyers Best Law Firms Badge 2016 American Board of Trial Advocates
Super Lawyers Badge for C. Todd Alley Super Lawyers Badge for Don Greiwe Super Lawyers Badge for James D. Clark National Board of Trial Advocacy Badge The National Trial Lawyers Badge 2015 Bay Area Legal Sustaining Law Firm
AV Preeminent Badge for James D. Clark AV Preeminent Badge for Donald G. Greiwe AV Preeminent Badge for C. Todd Alley AV Preeminent Badge for Alley, Clark & Greiwe

Contact Us

Alley, Clark & Greiwe

Street Address
201 N. Franklin, 7th Floor,
Tampa, FL 33602

General Email Inquiries:

Call Us 1-813-222-0977

P (813) 222-0977 | F (813) 224-0373

Free Case Evaluation